Original article
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
Seguridad y eficacia de tolvaptan en el tratamiento de los pacientes con enfermedad renal poliquística autosómica dominante: Revisión sistemática y metaanálisis
a Division of Nephrology, The First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei, China
b Division of Endocrinology, The Renhe Hospital of Three Gorges University, Yichang, Hubei, China
c Division of Urinary Surgery, The First College of Clinical Medical Science, Three Gorges University , Yichang, Hubei, China
Read
6327
Timeswas read the article
1576
Total PDF
4751
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 April | 154 | 38 | 192 |
| 2025 March | 150 | 78 | 228 |
| 2025 February | 144 | 41 | 185 |
| 2025 January | 153 | 41 | 194 |
| 2024 December | 102 | 40 | 142 |
| 2024 November | 95 | 65 | 160 |
| 2024 October | 124 | 57 | 181 |
| 2024 September | 105 | 48 | 153 |
| 2024 August | 125 | 91 | 216 |
| 2024 July | 130 | 47 | 177 |
| 2024 June | 149 | 42 | 191 |
| 2024 May | 159 | 55 | 214 |
| 2024 April | 147 | 51 | 198 |
| 2024 March | 157 | 35 | 192 |
| 2024 February | 100 | 44 | 144 |
| 2024 January | 84 | 31 | 115 |
| 2023 December | 162 | 41 | 203 |
| 2023 November | 134 | 57 | 191 |
| 2023 October | 122 | 50 | 172 |
| 2023 September | 366 | 33 | 399 |
| 2023 August | 429 | 25 | 454 |
| 2023 July | 434 | 31 | 465 |
| 2023 June | 177 | 28 | 205 |
| 2023 May | 150 | 69 | 219 |
| 2023 April | 105 | 40 | 145 |
| 2023 March | 89 | 57 | 146 |
| 2023 February | 73 | 49 | 122 |
| 2023 January | 70 | 46 | 116 |
| 2022 December | 95 | 46 | 141 |
| 2022 November | 111 | 78 | 189 |
| 2022 October | 156 | 122 | 278 |
Show all
